QNTA Stock Analysis
QN
Uncovered
Quanta Inc is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Quanta, Inc. operates as an applied science company. The company is headquartered in Burbank, California. The company went IPO on 2017-12-22. The firm operates, through its subsidiary, Medolife Rx, Inc. (Medolife). The firm is focused on a range of pharmaceutical, nutraceutical, topical relief and cosmetic products utilizing its patented polarization technology. The Company’s operations are based in Burbank, California. Medolife is a global biotechnology company with operations in clinical research, manufacturing, and consumer products. The Company’s lead clinical development programs include Escozine, a formulation consisting of small molecule peptides derived from Rhopalurus princeps scorpions, which is amplified by the Company’s polarization technology and is being researched as a treatment of various indications, including COVID-19 and cancer. Through its line of AELIA brand products, Medolife manufactures and distributes consumer wellness products in areas, such as pain relief, beauty, and general wellness.